Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epithelia

Molecular Pharmaceutics

Volumn 9, Issue 6, 2012, Pages 1717-1726

  Haghi, Mehra ^a   Traini, Daniela ^a   Bebawy, Mary ^b   Young, Paul M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

air interface model; Calu 3 epithelial cell line; dry powder inhaler; organic cation transporters (OCT); salbutamol

Indexed keywords

ORGANIC CATION TRANSPORTER; POLYESTER; SALBUTAMOL; SALBUTAMOL SULFATE; TRIETHYLAMINE;

ACTIVE TRANSPORT; ARTICLE; ARTIFICIAL MEMBRANE; BRONCHUS; CANCER CELL; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DIFFUSION; DRUG SOLUBILITY; DRUG TRANSPORT; DRUG UPTAKE; DRY DEPOSITION; DRY POWDER; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MEMBRANE MICROPARTICLE; PARTICULATE MATTER; POWDER INHALER; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; WESTERN BLOTTING;

ADMINISTRATION, INHALATION; ALBUTEROL; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MICROSCOPY, ELECTRON, SCANNING; RESPIRATORY MUCOSA;

EID: 84862001733     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200620m     Document Type: Article

References (43)

1. Telko, M. J.; Hickey, A. Dry Powder Inhaler Formulation. Respir. Care 2005, 50 (9), 1209-1227. (Pubitemid 46187575)
2. Widdicombe, J. H. Regulation of the Depth and Composition of Airway Surface Liquid. J. Anat. 2002, 201 (4), 313-318. (Pubitemid 35244050)
3. Patton, J. S.; Byron, P. R. Inhaling Medicines: Delivering Drugs to the Body Through the Lungs. Nat. Rev. Drug Discovery 2007, 6 (1), 67-74. (Pubitemid 46020287)
4. Grainger, C. I.; Greenwell, L. L.; Martin, G. P.; Forbes, B. The Permeability of Large Molecular Weight Solutes Following Particle Delivery to Air-Interfaced Cells That Model the Respiratory Mucosa. Eur. J. Pharm. Biopharm. 2009, 71 (2), 318-324.
5. Patton, J. S.; Davies, L. A.; Fiegel, J.; Gumbleton, M.; Kim, K. J.; Sakagami, M.; Vanbever, R.; Ehrhardt, C. The Particle Has Landed-Characterizing the Fate of Inhaled Pharmaceuticals. J. Aerosol Med. Pulm. Drug Delivery 2010, 2, S71-87.
6. Salama, R. Recent Advances in Controlled Release Pulmonary Therapy. Curr. Drug Delivery 2009, 6 (4), 404-414.
7. British Pharmacopoeia Appendix XII C; Stationery Office: London, 2011.
8. Hidalgo, I. J.; Li, J. Carrier-mediated Transport and Efflux Mechanisms in Caco-2 Cells. Adv. Drug Delivery Rev. 1996, 22 (1-2), 53-66. (Pubitemid 26423597)
9. Jashnani, R. N.; Dalby, R. N.; Byron, P. R. Preparation, Characterization, and Dissolution Kinetics of Two Novel Albuterol Salts. J. Pharm. Sci. 1993, 82 (6), 613-616. (Pubitemid 23216007)
10. Patton, J. S.; Fishburn, C. S.; Weers, J. G. The Lungs as a Portal of Entry for Systemic Drug Delivery. Proc. Am. Thorac. Soc. 2004, 1 (4), 338-344.
11. Salem, L. B.; Bosquillon, C.; Dailey, L. A.; Delattre, L.; Martin, G. P.; Evrard, B.; Forbes, B. Sparing Methylation of [beta]- Cyclodextrin Mitigates Cytotoxicity and Permeability Induction in Respiratory Epithelial Cell Layers In Vitro. J. Controlled Release 2009, 136 (2), 110-116.
12. Pezron, I.; Mitra, R.; Pal, D.; Mitra, A. K. Insulin Aggregation and Asymmetric Transport Across Human Bronchial Epithelial Cell Monolayers (Calu-3). J. Pharm. Sci. 2002, 91 (4), 1135-1146. (Pubitemid 34640938)
13. Zeng, X. M.; Martin, G. P.; Marriott, C. The Controlled Delivery of Drugs to the Lung. Int. J. Pharm. 1995, 124 (2), 149-164.
14. Salama, R. O.; Traini, D.; Chan, H.-K.; Young, P. M. Preparation and Characterisation of Controlled Release Co-Spray Dried Drug-Polymer Microparticles for Inhalation 2: Evaluation of In Vitro Release Profiling Methodologies for Controlled Release Respiratory Aerosols. Eur. J. Pharm. Biopharm. 2008, 70 (1), 145-152.
15. Franz, T. J. Percutaneous Absorption. On the Relevance of In Vitro Data. J. Invest. Dermatol. 1975, 64 (3), 190-195.
16. Adi, H.; Young, P. M.; Chan, H.-K.; Salama, R.; Traini, D. Controlled Release Antibiotics for Dry Powder Lung Delivery. Drug Dev. Ind. Pharm. 2010, 36 (1), 119-126.
17. Cook, R. O.; Pannu, R. K.; Kellaway, I. W. Novel Sustained Release Microspheres for Pulmonary Drug Delivery. J. Controlled Release 2005, 104 (1), 79-90. (Pubitemid 40615237)
18. Salama, R.; Ladd, L.; Chan, H.-K.; Traini, D.; Young, P. Development of an In Vivo Ovine Dry Powder Inhalation Model for the Evaluation of Conventional and Controlled Release Microparticles. AAPS J. 2009, 11 (3), 465-468.
19. Forbes, B. Human Airway Epithelial Cell Lines for In Vitro Drug Transport and Metabolism Studies. Pharm. Sci. Technol. Today 2000, 3 (1), 18-27. (Pubitemid 30066491)
20. Borchard, G.; Cassara, M. L.; Roemele, P. E. H.; Florea, B. I.; Junginger, H. E. Transport and Local Metabolism of Budesonide and Fluticasone Propionate in a Human Bronchial Epithelial Cell Line (Calu-3). J. Pharm. Sci. 2002, 91 (6), 1561-7.
21. Florea, B. I.; Cassara, M. L.; Junginger, H. E.; Borchard, G. Drug Transport and Metabolism Characteristics of the Human Airway Epithelial Cell Line Calu-3. J. Controlled Release 2003, 87 (1-3), 131-8. (Pubitemid 36255450)
22. Mathias, N. R.; Timoszyk, J.; Stetsko, P. I.; Megill, J. R.; Smith, R. L.; Wall, D. A. Permeability Characteristics of Calu-3 Human Bronchial Epithelial Cells: In Vitro-In Vivo Correlation to Predict Lung Absorption in Rats. J. Drug Targeting 2002, 10 (1), 31-40. (Pubitemid 34223847)
23. Haghi, M.; Young, P. M.; Traini, D.; Jaiswal, R.; Gong, J.; Bebawy, M. Time- and Passage-Dependent Characteristics of a Calu-3 Respiratory Epithelial Cell Model. Drug Dev. Ind. Pharm. 2010, 36 (10), 1207-1214.
24. Horvath, G.; Schmid, N.; Fragoso, M. A.; Schmid, A.; Conner, G. E.; Salathe, M.; Wanner, A. Epithelial Organic Cation Transporters Ensure pH-Dependent Drug Absorption in the Airway. Am. J. Respir. Cell Mol. Biol. 2007, 36 (1), 53-60. (Pubitemid 46067707)
25. Ehrhardt, C, K. C.; Bies, C; Lehr, C. M.; Kim, K. J.; Bakowsky, U. Salbutamol is actively absorbed across human bronchial epithelial cell layers. Pulm. Pharmacol. Ther. 2005, 18 (3), 165-170. (Pubitemid 40222110)
26. Endter, S.; Francombe, D.; Ehrhardt, C.; Gumbleton, M. RTPCR Analysis of ABC, SLC and SLCO Drug Transporters in Human Lung Epithelial Cell Models. J. Pharm. Pharmacol. 2009, 61 (5), 583-591.
27. Nakamura, T.; Nakanishi, T.; Haruta, T.; Shirasaka, Y.; Keogh, J. P.; Tamai, I. Transport of Ipratropium, an Anti-Chronic Obstructive Pulmonary Disease Drug, Is Mediated by Organic Cation/Carnitine Transporters in Human Bronchial Epithelial Cells: Implications for Carrier-Mediated Pulmonary Absorption. Mol. Pharmaceutics 2009, 7 (1), 187-195.
28. Bleasby, K.; Castle, J. C.; Roberts, C. J.; Cheng, C.; Bailey, W. J.; Sina, J. F.; Kulkarni, A. V.; Hafey, M. J.; Evers, R.; Johnson, J. M.; Ulrich, R. G.; Slatter, J. G. Expression Profiles of 50 Xenobiotic Transporter Genes in Humans and Pre-clinical Species: A Resource for Investigations into Drug Disposition. Xenobiotica 2006, 36 (10-11), 963-988. (Pubitemid 44844110)
29. Grainger, C.; Greenwell, L.; Lockley, D.; Martin, G.; Forbes, B. Culture of Calu-3 Cells at the Air Interface Provides a Representative Model of the Airway Epithelial Barrier. Pharm. Res. 2006, 23 (7), 1482-1490. (Pubitemid 43993811)
30. Bur, M.; Rothen-Rutishauser, B.; Huwer, H.; Lehr, C.-M.; Novel Cell, A Compatible Impingement System to Study In Vitro Drug Absorption from Dry Powder Aerosol Formulations. Eur. J. Pharm. Biopharm. 2009, 72 (2), 350-357.
31. Hein, S.; Bur, M.; Schaefer, U. F.; Lehr, C. M. A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to Evaluate Pulmonary Drug Absorption for Metered Dose Dry Powder Formulations. Eur. J. Pharm. Biopharm. 2011, 77 (1), 132-138.
32. Fiegel, J.; Ehrhardt, C.; Schaefer, U. F.; Lehr, C. M.; Hanes, J. Large Porous Particle Impingement on Lung Epithelial Cell Monolayers - Toward Improved Particle Characterization in the Lung. Pharm. Res. 2003, 20 (5), 788-796. (Pubitemid 36515312)
33. Cooney, D.; Kazantseva, M.; Hickey, A. J. Development of a Size-Dependent Aerosol Deposition Model Utilising Human Airway Epithelial Cells for Evaluating Aerosol Drug Delivery. Altern. Lab. Anim. 2004, 32 (6), 581-590. (Pubitemid 40321537)
34. Buttini, F.; Grainger, S.; Jones, S. A.; Royall, P. G.; Martin, G. P.; Forbes, B. In Characterization of Particles Emitted from Two Formulations of Beclomethasone Dipropionate Solution Metered Dose Inhalers; Respiratory Drug Delivery: Orlando, FL, 2008; pp 581-584.
35. Bur, M.; Huwer, H.; Muys, L.; Lehr, C. M. Drug Transport Across Pulmonary Epithelial Cell Monolayers: Effects of Particle Size, Apical Liquid Volume, and Deposition Technique. J. Aerosol Med. Pulm. Drug Delivery 2010, 23 (3), 119-127.
36. Tolnai, S. A Method for Viable Cell Count. Methods Cell Sci. 1975, 1 (1), 37-38.
37. Gruendemann, D.; Liebich, G.; Kiefer, N.; Koester, S.; Schoemig, E. Selective Substrates for Non-Neuronal Monoamine Transporters. Mol. Pharmacol. 1999, 56 (1), 1-10.
38. Pritchard, J. N. The influence of lung deposition on clinical response. J. Aerosol Med. 2001, 14 (Suppl.1), S19-S26. (Pubitemid 32172850)
39. Palacio, M. A.; Cuffini, S.; Badini, R.; Karlsson, A.; Palacios, S. M. Solid-State Characterization of Two Polymorphic Forms of R-Albuterol Sulfate. J. Pharm. Biomed. 2007, 43 (4), 1531-1534.
40. Marques, H. M. C.; Hadgraft, J.; Kellaway, I. W. Studies of Cyclodextrin Inclusion Complexes 0.1. The Salbutamol-Cyclodextrin Complex as Studied by Phase Solubility and DSC. Int. J. Pharm. 1990, 63 (3), 259-266.
41. Pharmacopoeia, B., Part II, Official Standards, Solubility. In British Pharmacopoeia Volume I & II; http://www.pharmacopoeia.co. uk: 2011.
42. Davies, N. M.; Feddah, M. R. A Novel Method for Assessing Dissolution of Aerosol Inhaler Products. Int. J. Pharm. 2003, 255 (1-2), 175-187. (Pubitemid 36369601)
43. Lin, H.; Yoo, J. W.; Roh, H. J.; Lee, M. K.; Chung, S. J.; Shim, C. K.; Kim, D. D. Transport of Anti-Allergic Drugs Across the Passage Cultured Human Nasal Epithelial Cell Monolayer. Eur. J. Pharm. Sci. 2005, 26 (2), 203-210.